Nervous Disorder TRIZ Cases

Viral-mediated Trpc3 knockdown in 5XFAD mice reduces beta-amyloid plaque accumulation and improves cognitive function.

Ex vivo genetic correction of hematopoietic stem cells using lentiviral vectors addresses underlying defects in lysosomal storage diseases.

Combining Hsp and mTOR inhibitors normalizes ciliation to treat TSC neuropsychiatric features beyond single-pathway therapy.

Antibodies bind P2X4 polypeptides to modulate ion channel conductance, addressing ineffective analgesic responses in neuropathic pain.

Exosome-mediated transport of endoplasmic reticulum chaperones inhibits amyloid protein aggregation in vitro and in vivo.

PEGylated anti-TNF antibodies extend half-life while maintaining high specificity for treating autoimmune disorders.

R-enantiomers of adrenergic beta-2 receptor agonists treat inflammatory bowel disease while reducing adverse effects associated with racemic forms.

RIPK2 inhibitors constrain microglia activation and reactive astrocyte formation, reducing neuroinflammatory mediators to halt disease progression.

TKTL1 serves as a specific intermediary marker to detect mammalian aerobic glucose fermentation, resolving the lack of precise metabolic pathway indicators.

Esylate and oxalate salts resolve hydrochloride polymorphism issues, ensuring consistent batch quality for kinase inhibitors.

Anti-tau antibodies distinguish normal from pathological tau states, eliminating false positives in Alzheimer's disease diagnostics.

A therapeutic apheresis method removes toxic oligomeric proteins from patient blood using red cell preparations and specific compounds.

Skull bone marrow niches supply Ly6C+ monocytes to meninges via direct dural connections, resolving uncertainty about border-resident cell origins.

Coupling degradable polymers with poly(amino acids) via DCC/DMAP/NHS catalysts, then removing residual solvents through dialysis to ensure biocompatibility.

Mutated estrogen receptor ligand binding domains enable precise drug-regulated chimeric antigen receptor expression in mammalian cells.

Anti-human IL-3 antibodies bind glycosylated epitopes to block cytokine activity in primary blood cells.

Novel RORγ modulator compounds inhibit target activity through specific structural modifications.

A honey and L-alanyl-L-glutamine composition improves sleep quality and duration through synergistic energy provision and blood-brain barrier penetration.

Halogen blocking in acid-catalyzed synthesis prevents unwanted isomer formation, reducing purification complexity.

Intraduodenal capsaicin regulates pyloric sphincter function to treat rapid gastric emptying and hypoglycemia without systemic side effects.

A hyperosmolar priming solution containing albumin and magnesium ions manages osmolality to protect brain tissue during medical interventions.

Receptor-mediated transcytosis bypasses blood-brain barrier impermeability, enabling targeted delivery of large molecular weight therapeutics.

Size selection isolates small mesenchymal stem cells to resolve heterogeneity, while hypoxic culture extends proliferative lifespan for GMP manufacturing.

Fully human CTLA4-binding proteins reduce patient immunogenicity and toxicity while maintaining therapeutic efficacy.

Direct synthesis of a novel 3,4-dihydroxyl pyridine chloride compound provides disease-modifying therapy for Parkinson's.

Long pentraxin PTX3 inhibits viral replication by binding pathogens and modulating immune responses, reducing toxicity in immunocompromised patients.

Immune regulatory oligonucleotide compounds inhibit toll-like receptor signaling through specific chemical modifications.

Aromatic-cationic peptides mitigate mitochondrial permeability transition, addressing inadequate therapeutic methods for oxidative damage.

Genotyping patients at SNP rs4306882 tailors esketamine dosing to improve reliability while minimizing adverse effects in resistant depression.

Small molecule splicing modulators based on heterocyclic amides target RNA cis-elements to alter transcript abundance.

Synthetic mimotope peptides trigger antibody production that binds and removes pathological alpha-synuclein proteins from neurons.

Spray-drying preserves essential oils in valerian and hop extracts, eliminating the unpleasant smell caused by traditional evaporation methods.

Fasinumab targets NGF to relieve joint pain without opioid toxicity.

High-density opioid conjugation on Qbeta VLPs elicits long-lasting antibodies without adjuvants or repeated boosts.

Acylation with acidic moieties resists DPP-IV degradation to reduce injection frequency for type 2 diabetes patients.

Isolated antibodies bind ADDLs to block neuronal binding, preventing tau phosphorylation and treating Alzheimer's without clearing plaques.

Triheptanoin supplies odd-carbon ketone bodies and Krebs cycle substrates to restore brain energy metabolism.

Human chorionic gonadotropin activates LH receptors to reduce toxicity from traditional antidepressants.

DOP-R1 agonists combined with DOP-R2 antagonists modulate neural activity to treat substance-related disorders.

Segmented scFv domains enable cellular penetration while PEST motifs direct tau to the proteasome for degradation.

Butyrylcholinesterase variants hydrolyze ghrelin into desacyl-ghrelin to downregulate active hormone levels.

Modified GLP-1 analogs resist DPP IV degradation, extending plasma half-life beyond thirty hours for sustained glucose control.

Targeting intermediate proteins in the ubiquitin-proteasome pathway increases mutant TPI stability without the toxicity of broad-spectrum inhibitors.

Chemically modified peptides derived from U1-70K spliceosomal protein modulate autophagy flux.

A protein kinase C inhibitor rescues memory function by stabilizing neuronal cell survival and reversing cognitive impairment.

Anti-CD49a antibodies block integrin signaling to reduce neurological damage from dysregulated immune activity.

A PKG inhibitor incorporates a low-molecular polyethylene glycol fragment to enhance water solubility.

A nutritional composition combines protein, omega-3 fatty acids, and polyphenols to support muscle strength and joint health in older adults.